A UK startup has built an AI-powered device capable of detecting signs of heart failure from a person’s feet. Cambridge-based Heartfelt Technologies says its technology can monitor discharged heart ...

Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. A conceptual image of ACIS, ...

Heart failure affects 6.5 million people in the U.S., with an additional 550,000 newly diagnosed each year. Heart failure hospitalizations are a leading cause of admissions for those 65 and older, ...

CHICAGO, Nov 14 (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that ...

CVRx’s stock has risen nearly 20% after the company revealed that its heart failure device is set to be investigated in an expanded patient population. In the BENEFIT-HF clinical trial (NCT07232030), ...

Physicians at Emory University Hospital performed the first-ever surgical implantation in the United States of a brand-new type of heart pump designed to help save patients with heart failure, using a ...

Institutional investors in the United States have committed to buy $3.5 million-worth of Sunshine Heart Inc. (ASX: SHC) shares in a private placement — that is, if the company’s Australian ...

Two implanted heart devices used by patients in end-stage heart failure are now under a strict U.S. Food and Drug Administration recall, after being tied to 273 known injuries and 14 deaths, the ...

Know the key differences, early symptoms, causes and treatment options to avoid confusion and ensure timely medical care in emergencies.

MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...